Zaid Said
University at Buffalo
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Zaid Said.
Proceedings of SPIE | 2017
Lauren Shepard; Kelsey Sommer; Richard L. Izzo; Alexander R. Podgorsak; Michael F. Wilson; Zaid Said; Frank J. Rybicki; Dimitrios Mitsouras; Stephen Rudin; Erin Angel; Ciprian N. Ionita
Purpose: Accurate patient-specific phantoms for device testing or endovascular treatment planning can be 3D printed. We expand the applicability of this approach for cardiovascular disease, in particular, for CT-geometry derived benchtop measurements of Fractional Flow Reserve, the reference standard for determination of significant individual coronary artery atherosclerotic lesions. Materials and Methods: Coronary CT Angiography (CTA) images during a single heartbeat were acquired with a 320x0.5mm detector row scanner (Toshiba Aquilion ONE). These coronary CTA images were used to create 4 patientspecific cardiovascular models with various grades of stenosis: severe, <75% (n=1); moderate, 50-70% (n=1); and mild, <50% (n=2). DICOM volumetric images were segmented using a 3D workstation (Vitrea, Vital Images); the output was used to generate STL files (using AutoDesk Meshmixer), and further processed to create 3D printable geometries for flow experiments. Multi-material printed models (Stratasys Connex3) were connected to a programmable pulsatile pump, and the pressure was measured proximal and distal to the stenosis using pressure transducers. Compliance chambers were used before and after the model to modulate the pressure wave. A flow sensor was used to ensure flow rates within physiological reported values. Results: 3D model based FFR measurements correlated well with stenosis severity. FFR measurements for each stenosis grade were: 0.8 severe, 0.7 moderate and 0.88 mild. Conclusions: 3D printed models of patient-specific coronary arteries allows for accurate benchtop diagnosis of FFR. This approach can be used as a future diagnostic tool or for testing CT image-based FFR methods.
Pacing and Clinical Electrophysiology | 2018
Wassim Mosleh; Ali Sheikh; Zaid Said; Mohamed Abdel-Aal Ahmed; Siri Gadde; Tanvi Shah; Michael F. Wilson; Hiroko Beck; Chee Kim; Umesh Sharma
Atrial fibrillation (AF) is a growing financial burden on the healthcare system. Cardiac computed tomographic angiography (CCTA) is needed for pulmonary vein mapping before AF ablation (AFA). CCTA has shown to be an alternative to transesophageal echocardiogram (TEE) to rule out left atrial appendage thrombus (LAAT) pre‐AFA. We aim to examine the safety, cost‐effectiveness, and time‐efficiency of utilizing CCTA alone to rule out LAAT before AFA.
Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine | 2018
Narasa Madam; Wassim Mosleh; Natdanai Punnanithinont; Andres Carmona-Rubio; Zaid Said; Umesh Sharma
Background: Pulmonary hypertension (PH) is an underdiagnosed cause for chest pain in patients without significant coronary artery disease (CAD). Studies showed that enlarged pulmonary arterial (PA) and right ventricular chamber sizes correlate with the severity of PH. Therefore, we studied the association between chest pain, right ventricular dimensions (RVDs), and PA size on coronary coronary tomographic angiography (CCTA). Methods: The CCTA of 87 patients presenting with chest pain without evidence of obstructive CAD was examined. The PA diameter (PAD), right atrial dimension (RAD), and RVD were measured. A comparative control cohort included 31 patients who presented without cardiopulmonary complaints and underwent thoracic CT. The risk for obstructive sleep apnea (OSA) was assessed using STOP-BANG questionnaires. Results: Patients with chest pain without obstructive CAD showed markedly dilated right atrial and ventricular chambers compared with standard parameters (right atrium: 48 ± 6.4 mm; right ventricle long axis: 61 ± 9.5 mm). When comparing chest pain vs non-chest pain group, respectively, the mean PAD measured 25.92 ± 0.43 mm vs 22.89 ± 0.38 mm (P < .001), RAD2 measured 40.1423 ± 0.7108 mm vs 34.8800 ± 1.0245 mm (P = .0048), and RVD2 measured 31.7729 ± 0.7299 mm vs 27.6379 ± 1.6178 mm (P = .034). Chest pain was associated with higher PAD (odds ratio [OR]: 11.11, P < .05) after adjusting for age, sex, body mass index, history of hypertension, hyperlipidemia, congestive heart failure, chronic obstructive pulmonary disease, OSA, and smoking. The chest pain group had a mean STOP-BANG score of 3.9 ± 1.8 in all patients, and 3.62 ± 0.20 in patients without known history of OSA, representing an elevated risk index for the disease. Conclusions: In patients presenting with chest pain without obstructive CAD on CCTA, there is a strong association between the presence of chest pain and enlarged PAD. They also represent a high-risk group for OSA.
The American Journal of Medicine | 2017
Robert Faillace; Gregory W. Yost; Yashasvi Chugh; Jeffrey Adams; Beni Verma; Zaid Said; Ibrahim Ismail Sayed; Ashley Honushefsky; Sanjay Doddamani; Peter B. Berger
BACKGROUND The Centers for Medicare and Medicaid Services (CMS) model for publicly reporting national 30-day-risk-adjusted mortality rates for patients admitted with heart failure fails to include clinical variables known to impact total mortality or take into consideration the culture of end-of-life care. We sought to determine if those variables were related to the 30-day mortality of heart failure patients at Geisinger Medical Center. METHODS Electronic records were searched for patients with a diagnosis of heart failure who died from any cause during hospitalization or within 30 days of admission. RESULTS There were 646 heart-failure-related admissions among 530 patients (1.2 admissions/patient). Sixty-seven of the 530 (13%) patients died: 35 (52%) died during their hospitalization and 32 (48%) died after discharge but within 30 days of admission; of these, 27 (40%) had been transferred in for higher-acuity care. Fifty-one (76%) died from heart failure, and 16 (24%) from other causes. Fifty-five (82%) patients were classified as American Heart Association Stage D, 58 (87%) as New York Heart Association Class IV, and 30 (45%) had right-ventricular systolic dysfunction. None of the 32 patients who died after discharge met recommendations for beta-blockers. Criteria for prescribing angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and mineralocorticoid receptor blockers were not met by 33 of the 34 patients (97%) with heart failure with reduced ejection fraction not on one of those drugs. Fifty-seven patients (85%) had a do-not-resuscitate (DNR) status. CONCLUSION A majority of heart failure-related mortality was among patients who opted for a DNR status with end-stage heart failure, limiting the appropriateness of administering evidence-based therapies. No care gaps were identified that contributed to mortality at our institution. The CMS 30-day model fails to take important variables into consideration.
Proceedings of SPIE | 2017
Kelsey Sommer; Rick L. Izzo; Lauren Shepard; Alexander R. Podgorsak; Stephen Rudin; Adnan H. Siddiqui; Michael F. Wilson; Erin Angel; Zaid Said; Michael Springer; Ciprian N. Ionita
3D printing has been used to create complex arterial phantoms to advance device testing and physiological condition evaluation. Stereolithographic (STL) files of patient-specific cardiovascular anatomy are acquired to build cardiac vasculature through advanced mesh-manipulation techniques. Management of distal branches in the arterial tree is important to make such phantoms practicable. We investigated methods to manage the distal arterial flow resistance and pressure thus creating physiologically and geometrically accurate phantoms that can be used for simulations of image-guided interventional procedures with new devices. Patient specific CT data were imported into a Vital Imaging workstation, segmented, and exported as STL files. Using a mesh-manipulation program (Meshmixer) we created flow models of the coronary tree. Distal arteries were connected to a compliance chamber. The phantom was then printed using a Stratasys Connex3 multimaterial printer: the vessel in TangoPlus and the fluid flow simulation chamber in Vero. The model was connected to a programmable pump and pressure sensors measured flow characteristics through the phantoms. Physiological flow simulations for patient-specific vasculature were done for six cardiac models (three different vasculatures comparing two new designs). For the coronary phantom we obtained physiologically relevant waves which oscillated between 80 and 120 mmHg and a flow rate of ~125 ml/min, within the literature reported values. The pressure wave was similar with those acquired in human patients. Thus we demonstrated that 3D printed phantoms can be used not only to reproduce the correct patient anatomy for device testing in image-guided interventions, but also for physiological simulations. This has great potential to advance treatment assessment and diagnosis.
Journal of the American College of Cardiology | 2017
Ali Sheikh; Zaid Said; Mohamed Abdel-Aal Ahmed; Wassim Mosleh; Michael F. Wilson; Hiroko Beck; Chee Kim; Umesh Sharma
Background: Atrial fibrillation (AF) is an ever-increasing problem with growing financial burden on the healthcare system.
Journal of the American College of Cardiology | 2016
Abhishek C. Sawant; Vasvi Singh; Kevin Josey; Meg Plomondon; Thomas M. Maddox; Ali Sheikh; Zaid Said; Bharath Rajagopalan; Deepak L. Bhatt; John Corbelli
6 billion a year has been attributed directly to AF. Peri-procedural imaging in patients undergoing atrial fibrillation ablation (AFA) is estimated at
Journal of the American College of Cardiology | 2016
Zaid Said; Narasa Madam; Ali Sheikh; Sebastian Wilk; Saurabh Malhotra
1,200, roughly 6% of
Jacc-cardiovascular Interventions | 2017
Abhishek C. Sawant; Kevin Josey; Thomas M. Maddox; Aishwarya Bhardwaj; Vasvi Singh; Bharath Rajagopalan; Zaid Said; Deepak L. Bhatt; John Corbelli
TCT-334 Predictors of Outcomes Among Nonagenarians Undergoing Percutaneous Coronary Intervention: A National Veterans Affairs Database Study Abhishek Sawant, Vasvi Singh, Kevin Josey, Meg Plomondon, Thomas Maddox, Ali Sheikh, Zaid Said, Bharath Rajagopalan, Deepak Bhatt, John Corbelli State University of New York at Buffalo, Buffalo, New York, United States; Clinical centre of Serbia; Clinical centre of Serbia; Niguarda Hospital; Kurume-univaersity; Kurume-univaersity; University of Glasgow; Golden Jubilee National Hospital; Brigham and Women’s Hospital, Boston, Massachusetts, United States; School of Medicine, University of California, Irvine
Journal of the American College of Cardiology | 2018
Bharath Rajagopalan; Zaid Said; Laura Ford-Mukkamala; Saurabh Malhotra
Pulmonary embolism (PE) is a potentially fatal condition that can be readily diagnosed by ventilation/perfusion (V/Q) scans or Computed Tomography Angiography (CTA). However, there can be interpretative pitfalls, especially in patients with complex congenital heart disease (CHD). As more patients